Siemens Healthcare is expanding its portfolio for cancer therapy by partnering with IMPAC Medical Systems, Inc. (IMPAC) which includes an extension of its software distribution agreement to 2016 and adding the MOSAIQ software to its oncology portfolio. Under the extended agreement, Siemens will offer the MOSAIQ software as its next generation OIS offering to LANTIS, the OIS currently sold by Siemens.
Siemens LANTIS customers will have the option of upgrading to MOSAIQ or continuing to utilize their LANTIS systems. Siemens will extend service support and application training for its customers to include MOSAIQ.
Moreover, Siemens and IMPAC will work together to develop interfaces between MOSAIQ and IONTRIS, making it possible to use MOSAIQ with Siemens particle therapy solutions in the future.
IMPAC, part of the Elekta Group, provides software solutions that streamline clinical and business operations across the spectrum of cancer care.